vs
信安金融集团（PFG）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
信安金融集团的季度营收约是Royalty Pharma plc的1.2倍（$750.8M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 0.3%，领先34.2%），Royalty Pharma plc同比增速更快（4.8% vs 4.0%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -58.3%）
信安金融集团（股票代码：PFG）是总部位于美国艾奥瓦州得梅因的全球性金融服务企业，核心业务涵盖投资管理、保险服务两大板块，在全球多个区域开展业务，为机构客户和个人用户提供专业定制化的金融解决方案，在行业内拥有较高知名度。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PFG vs RPRX — 直观对比
营收规模更大
PFG
是对方的1.2倍
$622.0M
营收增速更快
RPRX
高出0.8%
4.0%
净利率更高
RPRX
高出34.2%
0.3%
两年增速更快
RPRX
近两年复合增速
-58.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $750.8M | $622.0M |
| 净利润 | $1.9M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 0.3% | 34.4% |
| 营收同比 | 4.0% | 4.8% |
| 净利润同比 | 783.0% | 2.9% |
| 每股收益（稀释后） | — | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PFGRPRX
| Q1 26 | $750.8M | — | ||
| Q4 25 | $4.6B | $622.0M | ||
| Q3 25 | $3.7B | $609.3M | ||
| Q2 25 | $3.7B | $578.7M | ||
| Q1 25 | $3.7B | $568.2M | ||
| Q4 24 | $4.8B | $593.6M | ||
| Q3 24 | $3.0B | $564.7M | ||
| Q2 24 | $4.3B | $537.3M |
净利润PFGRPRX
| Q1 26 | $1.9M | — | ||
| Q4 25 | $517.0M | $214.2M | ||
| Q3 25 | $213.8M | $288.2M | ||
| Q2 25 | $406.2M | $30.2M | ||
| Q1 25 | $48.1M | $238.3M | ||
| Q4 24 | $905.4M | $208.2M | ||
| Q3 24 | $-220.0M | $544.0M | ||
| Q2 24 | $353.1M | $102.0M |
营业利润率PFGRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 62.4% | ||
| Q3 25 | — | 70.1% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 50.2% |
净利率PFGRPRX
| Q1 26 | 0.3% | — | ||
| Q4 25 | 11.3% | 34.4% | ||
| Q3 25 | 5.8% | 47.3% | ||
| Q2 25 | 11.1% | 5.2% | ||
| Q1 25 | 1.3% | 41.9% | ||
| Q4 24 | 19.1% | 35.1% | ||
| Q3 24 | -7.3% | 96.3% | ||
| Q2 24 | 8.2% | 19.0% |
每股收益（稀释后）PFGRPRX
| Q1 26 | — | — | ||
| Q4 25 | $2.30 | $0.49 | ||
| Q3 25 | $0.95 | $0.67 | ||
| Q2 25 | $1.79 | $0.07 | ||
| Q1 25 | $0.21 | $0.55 | ||
| Q4 24 | $3.92 | $0.46 | ||
| Q3 24 | $-0.95 | $1.21 | ||
| Q2 24 | $1.49 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | — | $9.7B |
| 总资产 | — | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PFGRPRX
| Q1 26 | — | — | ||
| Q4 25 | $4.4B | $618.7M | ||
| Q3 25 | $5.1B | $938.9M | ||
| Q2 25 | $3.7B | $631.9M | ||
| Q1 25 | $3.9B | $1.1B | ||
| Q4 24 | $4.2B | $929.0M | ||
| Q3 24 | $6.2B | $950.1M | ||
| Q2 24 | $4.8B | $1.8B |
总债务PFGRPRX
| Q1 26 | — | — | ||
| Q4 25 | $3.9B | $9.0B | ||
| Q3 25 | $3.9B | $8.9B | ||
| Q2 25 | $3.9B | $8.0B | ||
| Q1 25 | $4.3B | $7.6B | ||
| Q4 24 | $4.0B | $7.6B | ||
| Q3 24 | $3.9B | $7.6B | ||
| Q2 24 | $3.9B | $7.6B |
股东权益PFGRPRX
| Q1 26 | — | — | ||
| Q4 25 | $11.9B | $9.7B | ||
| Q3 25 | $11.7B | $9.6B | ||
| Q2 25 | $11.4B | $9.5B | ||
| Q1 25 | $11.2B | $9.8B | ||
| Q4 24 | $11.1B | $10.3B | ||
| Q3 24 | $11.2B | $10.3B | ||
| Q2 24 | $11.0B | $9.8B |
总资产PFGRPRX
| Q1 26 | — | — | ||
| Q4 25 | $341.4B | $19.6B | ||
| Q3 25 | $334.5B | $19.3B | ||
| Q2 25 | $323.1B | $18.3B | ||
| Q1 25 | $313.0B | $17.6B | ||
| Q4 24 | $313.7B | $18.2B | ||
| Q3 24 | $322.9B | $18.0B | ||
| Q2 24 | $308.8B | $17.7B |
负债/权益比PFGRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.33× | 0.92× | ||
| Q3 25 | 0.34× | 0.93× | ||
| Q2 25 | 0.34× | 0.84× | ||
| Q1 25 | 0.39× | 0.78× | ||
| Q4 24 | 0.36× | 0.74× | ||
| Q3 24 | 0.35× | 0.74× | ||
| Q2 24 | 0.36× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PFGRPRX
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $827.1M | ||
| Q3 25 | $1.0B | $702.6M | ||
| Q2 25 | $811.9M | $364.0M | ||
| Q1 25 | $977.3M | $596.1M | ||
| Q4 24 | $1.5B | $742.5M | ||
| Q3 24 | $1.1B | $703.6M | ||
| Q2 24 | $1.4B | $658.2M |
现金转化率PFGRPRX
| Q1 26 | — | — | ||
| Q4 25 | 3.37× | 3.86× | ||
| Q3 25 | 4.70× | 2.44× | ||
| Q2 25 | 2.00× | 12.06× | ||
| Q1 25 | 20.32× | 2.50× | ||
| Q4 24 | 1.61× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 4.05× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PFG
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
